Visfatin levels in female, morbid, nondiabetic obese patients after biliopancreatic diversion surgery.
de Luis
Daniel Antonio
DA
Institute of Endocrinology and Nutrition, Medicine School, Unit of Investigation, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain. dadluis@yahoo.es
Izaola
Olatz
O
Conde
Rosa
R
Primo
David
D
Sagrado
Manuel González
MG
Aller
Rocio
R
D015904:Biliopancreatic Diversion / Q000009:adverse effects*; D015415:Biomarkers / Q000097:blood; D015992:Body Mass Index; D003920:Diabetes Mellitus; D018450:Disease Progression; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D050152:Intra-Abdominal Fat / Q000378:metabolism; D008875:Middle Aged; D054409:Nicotinamide Phosphoribosyltransferase / Q000096:biosynthesis / Q000097:blood*; D009767:Obesity, Morbid / Q000097:blood / Q000601:surgery*; D011184:Postoperative Period; D011446:Prospective Studies; D012720:Severity of Illness Index; D013997:Time Factors
D015415:Biomarkers; D054409:Nicotinamide Phosphoribosyltransferase